Sutro Biopharma Inc.

NASDAQ: STRO · Real-Time Price · USD
0.88
0.10 (12.81%)
At close: Aug 15, 2025, 3:59 PM
0.88
0.02%
After-hours: Aug 15, 2025, 04:12 PM EDT

Sutro Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
62.04M 153.73M 67.77M 61.88M
Cost of Revenue
7.22M 6.82M 8.29M 9.77M
Gross Profit
54.83M 146.91M 59.48M 52.11M
Operating Income
-238.45M -89.28M -128.94M -98.52M
Interest Income
44.42M 14.51M 3.46M 577K
Pretax Income
-225.1M -88.6M -116.7M -105.54M
Net Income
-227.46M -106.79M -119.2M -105.54M
Selling & General & Admin
48.45M 62.58M 59.54M 56M
Research & Development
252.04M 180.43M 137.17M 104.4M
Other Expenses
-7.22M -6.82M -8.29M -9.77M
Operating Expenses
293.28M 236.19M 188.43M 150.63M
Interest Expense
31.07M 23.75M 3.35M 3.14M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
300.5M 243.01M 196.72M 160.4M
Income Tax Expense
2.36M 18.19M 2.5M n/a
Shares Outstanding (Basic)
76.83M 60.16M 50.74M 46.12M
Shares Outstanding (Diluted)
76.83M 60.16M 50.74M 46.12M
EPS (Basic)
-2.96 -1.78 -2.35 -2.29
EPS (Diluted)
-2.96 -1.78 -2.35 -2.29
EBITDA
-180.45M -67.92M -105.07M -97.56M
EBIT
-187.67M -74.73M -113.36M -102.4M
Depreciation & Amortization
7.22M 6.82M 8.29M 4.84M